skip to main content
React to this bill with an emoji:
Save your position on this bill bill on a six-point scale from strongly oppose to strongly support:

H.R. 4748 (111th): Northern Border Counternarcotics Strategy Act of 2010

The text of the bill below is as of Mar 3, 2010 (Introduced).

Source: GPO

I

111th CONGRESS

2d Session

H. R. 4748

IN THE HOUSE OF REPRESENTATIVES

March 3, 2010

(for himself, Mr. Thompson of Mississippi, Mrs. McMorris Rodgers, Mr. Pascrell, and Ms. Kaptur) introduced the following bill; which was referred to the Committee on the Judiciary, and in addition to the Committee on Homeland Security, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend the Office of National Drug Control Policy Reauthorization Act of 2006 to require a northern border counternarcotics strategy, and for other purposes.

1.

Short title

This Act may be cited as the Northern Border Counternarcotics Strategy Act of 2010.

2.

Northern Border Counternarcotics Strategy

The Office of National Drug Control Policy Reauthorization Act of 2006 (Public Law 109–469) is amended by inserting after section 1110 the following new section:

1110A.

Requirement for Northern Border Counternarcotics Strategy

(a)

In general

Not later than 120 days after the date of the enactment of this section and every two years thereafter, the Director of National Drug Control Policy, in coordination with the Secretary of Homeland Security, shall submit to Congress a Northern Border Counternarcotics Strategy.

(b)

Purposes

The Northern Border Counternarcotics Strategy shall—

(1)

set forth the Government’s strategy for preventing the illegal trafficking of drugs across the international border between the United States and Canada, including through ports of entry and between ports of entry on that border;

(2)

state the specific roles and responsibilities of the relevant National Drug Control Program agencies (as defined in section 702 of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1701)) and the Office of Counternarcotics Enforcement of the Department of Homeland Security for implementing that strategy; and

(3)

identify the specific resources required to enable the relevant National Drug Control Program agencies and the Office of Counternarcotics Enforcement of the Department of Homeland Security to implement that strategy.

(c)

Specific content related to cross-Border Indian reservations

The Northern Border Counternarcotics Strategy shall include—

(1)

a strategy to end the illegal trafficking of drugs through Indian reservations that straddle the international border between the United States and Canada; and

(2)

recommendations for additional assistance to tribal law enforcement agencies with respect to such strategy.

(d)

Consultation with other agencies

The Director shall issue the Northern Border Counternarcotics Strategy in consultation with the heads of the relevant National Drug Control Program agencies.

(e)

Limitation

The Northern Border Counternarcotics Strategy shall not change existing agency authorities or the laws governing interagency relationships, but may include recommendations about changes to such authorities or laws.

(f)

Report to Congress

The Director shall provide a copy of the Northern Border Counternarcotics Strategy to the appropriate congressional committees (as defined in section 702 of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1701)), and to the Committee on Armed Services and the Committee on Homeland Security of the House of Representatives, and the Committee on Homeland Security and Governmental Affairs and the Committee on Armed Services of the Senate.

(g)

Treatment of classified or law enforcement sensitive information

Any content of the Northern Border Counternarcotics Strategy that involves information classified under criteria established by an Executive order, or whose public disclosure, as determined by the Director or the head of any relevant National Drug Control Program agency, would be detrimental to the law enforcement or national security activities of any Federal, State, local, or tribal agency, shall be presented to Congress separately from the rest of the Strategy.

.